33
/de/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
2135666
178559
2
Create a timeline
Public Timelines
For education
For educational institutions
For teachers
For students
Cabinet
For educational institutions
For teachers
For students
Open cabinet
FAQ
Das Premium bekommen
Close
Create a timeline
Public timelines
FAQ
About & Feedback
Vereinbarung
Privatheit
FAQ
Support 24/7
Cabinet
Get premium
Donate
8 Jun 2017 Jahr - FDA requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market based on its concern that the benefits of the drug may no longer outweigh its risks.
Zugefügt zum Band der Zeit:
Opioids and the FDA
By
Anastasia
13 Nov 2018
0
0
523
Datum:
8 Jun 2017 Jahr
Jetzt
~ 8 years and 4 months ago
About & Feedback
Vereinbarung
Privatheit
FAQ
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL